Companion Diagnostics

Tarceva diagnostic brings new indication

Tarceva diagnostic brings new indication

By

Tarceva picks up a first-line indication and a companion diagnostic

Tysabri gets boost from label change, new diagnostic

Tysabri gets boost from label change, new diagnostic

By

Biogen Idec and Elan, which market Tysabri for multiple sclerosis, won approval to add new safety information to the drug's label that could boost sales by helping doctors avoid a serious adverse event.

Pfizer's Xalkori and Abbott test show promise in personalized medicine, companion diagnostics

By

The FDA's approval of Pfizer's Xalkori (crizotinib) represents a leap forward for both personalized medicine and Pfizer's R&D turnaround, but its commercial success hinges on a pricey diagnostic array by Abbott's Vysis.

Email Newsletters